1 / 6

Public Health Response to Genital Herpes

Public Health Response to Genital Herpes. Use of HSV-2 Serologies for Dx. Dx of genital lesions/symptoms- yes performance of two step approach pcr vs.serologic testing for lesion resources to pay for serologic testing. Use of HSV-2 Serologies for Dx and Screening in STD Clinics.

amma
Download Presentation

Public Health Response to Genital Herpes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Public Health Response to Genital Herpes

  2. Use of HSV-2 Serologies for Dx • Dx of genital lesions/symptoms- yes performance of two step approach pcr vs.serologic testing for lesion resources to pay for serologic testing

  3. Use of HSV-2 Serologies for Dxand Screening in STD Clinics • Implementation training of staff impact on clinic flow screening pre and post test counseling serologic screening and therapy cost follow-up

  4. HSV-2 Serologic Testing HIV Positive • Time for symptom screen • Strongly consider screening all HIV-positives • Move HIV Treatment guidelines forward to include screening considerations and treatment recommendations

  5. Screening in partnerships with HSV-2 discordance • Yes, esp. with recent transmission data • Where to offer screening • Counseling and treatment guidelines fro prevention of transmission • Recommendations for follow up

  6. Screening • General population-NO • Universal screening in pregnancy- the debate continues Needs: Neonatal HSV as reportable disease Impact on c-section rates Feasibility outside of Seattle Impact of test performance in low prevalence areas

More Related